Lyell Immunopharma Investor
Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.
Technology:
Cell_Therapies
Headquarters:
South San Francisco, California, United States
Founded Date:
2018-01-01
Employees Number:
251-500
Number Of Exits:
1
Investors Number:
4
Total Funding:
492999957
Estimated Revenue:
$10M to $50M
Last Funding Date:
2020-03-12
Last Funding Type:
Series C
Register and Claim Ownership